(R)-Blovacitinib

Overview

(R)-Blovacitinib ((R)-TUL01101) is a JAK1 -selective inhibitor with an IC 50 of 45 nM. (R)-Blovacitinib inhibits JAK1-mediated cytokine signaling pathways. (R)-Blovacitinib can be used for the research of rheumatoid arthritis.

Application

Products | Products > Disease Areas > Arthritis | Products > Disease Areas > Rheumatoid Arthritis | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Disease Areas > Autoimmune Disease | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > JAK/STAT Signaling | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > JAK

Product Information

• Catalog No.: HY-152080A
• CAS No.: 2411222-96-1
• Molecular Formula: C22H25F2N5O2
• Molecular Weight: 429.46
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source